Daewoong's Nabota tops botulinum toxin exports
Daewoong Pharmaceutical said Tuesday that its botulinum toxin product, Nabota, posted 113.3 billion won ($85.3 million) in sales as of the third quarter this year.
Overseas sales made up 93.5 billion won or 83 percent of the total, the company added.
Nabota's overseas sales have continued growing in recent years, an outcome of Daewoon's global push. The portion reached 61 percent in 2021 and then surged to 77 percent last year.
US sales, in particular, reached 44.5 billion won, making up more than 50 percent of global sales.
“Nabota’s share in the US botulinum toxin market has surged over the last two years. We expect to further boost our share in the future," a Daewoong official said.
Nabota, sold as Jeuveau in the US, made its US debut in 2020 through local partner Evolus’ botulinum toxin treatment program. Nabota currently has around an 11 percent share in the US botulinum toxin market, according to the company.
“Nabota was able to take the lead among Korea’s botulinum toxin products as Daewoong set its plans ahead for its launch in the US and received approval from the US Food and Drug Administration fast,” said Park Seong-soo, vice president of Daewoong Pharmaceutical.
In South Korea, a total of 11 botulinum toxin products have received approval from the government so far, and three additional products are under review.
Daewoong said the company will speed up Nabota launches in European countries, including Germany, Italy and Austria.
The company added it would also make a foray into the Malaysian market soon. In August, Daewoong received sales approval from the National Pharmaceutical Regulatory Agency in Malaysia.
(责任编辑:패션)
下一篇:[Korean History] Deadly sinking of Navy ship in 2010 marks worst postwar military disaster
- ·Everland grounds panda Fubao for trying to escape
- ·Negotiating members of Indo
- ·Surf's up: Enhypen enjoys the ride with 'Orange Blood'
- ·윤희숙 "20여년 억대 연봉 송영길이 돈 없다? 못된 버릇 때문"
- ·Suneung difficulty rekindles 'killer question' controversy
- ·SK hynix wins 2023 R&D 100 Awards
- ·Network error grinds government network to halt, restoration still in progress
- ·LG celebrates 1st baseball championship in 29 years with discounts
- ·Lucy returns with 'Boogie Man'
- ·Journey to Joseon scholars' timeless dwellings
- ·송영길 "어린 건방진 놈" 한동훈 "운동권 했다고 우월한 척"
- ·CATL reduces gap with LG Energy Solution
- ·6 outgoing ministers ‘strong candidates’ for general elections: ruling party
- ·인요한 "변하든지 죽든지…말 듣지 않으면 매도 들 수 있다"
- ·Jeju female divers 'haenyeo' listed as FAO agricultural heritage system
- ·Stalking crimes could lead to up to 5 years in prison custody
- ·Scalpers take bigger cut of Korean music industry
- ·[From the Scene] 20
- ·'Making economy more dynamic a top priority': finance minister nominee
- ·NewJeans to be first K
- ·[New on the Scene] Joo Jong
- ·"중동사태, 특등 전쟁상인 美 때문"…불법무기상 北 적반하장
- ·Over 70,000 teens homeless, urgent support needed: professor
- ·Park Bom to return with new single ‘I’
- ·Jeju female divers 'haenyeo' listed as FAO agricultural heritage system
- ·[From the Scene] 20
- ·Warmer winter temperatures expected this week
- ·[Herald Interview] Singer